Changing the Practice of Medicine
Popular
MinuteCE®Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
0.50 program credits
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
Saad Z. Usmani, MD, MBA
Natalie S. Callander, MD
Saad Z. Usmani, MD, MBA
Natalie S. Callander, MD
Kathleen N. Moore, MD
Ritu Salani, MD
Kathleen N. Moore, MD
Ritu Salani, MD
- MinuteCE®
The Survival Ceiling in ES-SCLC: Why Checkpoint Blockade Alone Is Not Enough
0.50 program creditsNeal Ready, MD, PhD
CME/CE
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
Kathleen N. Moore, MD
Ritu Salani, MD
Kathleen N. Moore, MD
Ritu Salani, MD
Sara A. Hurvitz, MD, FACP
Tiffany Traina, MD
- MinuteCE®
Rationale of Emerging Antigen-Directed Strategies in Frontline ES-SCLC
0.50 program creditsNeal Ready, MD, PhD
Neal Ready, MD, PhD
Ticiana Leal, MD
Clinical Practice
Virginia Kaklamani, MD, DSc
Kathleen N. Moore, MD
Ritu Salani, MD
Ticiana Leal, MD
- MinuteCE®
Building the Team: Integrating Immunotherapy Into Multidisciplinary Care
0.50 program creditsChristophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
- MinuteCE®
The Case for Change: Why Perioperative Immunotherapy Matters in LA HNSCC
0.50 program creditsChristophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
Programs
- MinuteCE®
On the Horizon: Emerging Antigen-Directed Strategies Across Disease Stage
0.50 program creditsTiciana Leal, MD
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
- MinuteCE®
Cracking the Code: Risk Stratification Guidelines to Identify High-Risk Patients
1.00 program creditScott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Tiffany Traina, MD
Javier Cortes, MD, PhD